Just before the 23andMe SPAC deal closed, the stock belonging to its merger ... giving investors the impression it is a ...

Me collected information from survey questions about personal health and beyond, such as drinking habits and risk tolerance.

Me on Sunday filed for bankruptcy in the U.S. after struggling with weak demand for its ancestry testing kits and a 2023 data ...

American biotechnology company 23andMe filed for Chapter 11 bankruptcy this month, after several quarters of falling revenue. The filing has put the data of millions of users’ data up for grabs ...

Me is pursuing a sale after filing for bankruptcy, leading many customers to look into deleting their data from the company.

The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Kayte Spector-Bagdady, University of Michigan (THE CONVERSATION) As soon as the ...

Mergers with SPACs have been a way for companies to get public-market listings without the heavy scrutiny of the IPO process 23andMe is going bankrupt - underscoring the great risks of investing ...

23andMe bankruptcy underscores the risk of investing in most SPACs. - MarketWatch photo illustration/iStockphoto 23andMe is going bankrupt — underscoring the great ...